In short
Different drug classes with different mechanisms, different histories and different regulatory positions. Phentermine is a stimulant appetite suppressant.
By Alsen Walker · Updated September 20, 2026
Different drug classes with different mechanisms, different histories and different regulatory positions. Phentermine is a stimulant appetite suppressant approved for short-term use. GLP-1 medications work on appetite regulation and gut hormones and are used long term. That difference in intended duration is the most important thing separating them.
Phentermine is not suitable for everyone. As a stimulant it can raise heart rate and blood pressure, and it has contraindications including certain cardiovascular conditions, hyperthyroidism, glaucoma, and use with some other medications including certain antidepressants. It is a controlled substance in the US. These are prescriber decisions and not things to work around.
For how this fits alongside the other comparisons, and what actually decides the choice, see Comparing GLP-1 Medications: How to Actually Choose.
How each works
Phentermine is a sympathomimetic that suppresses appetite through central stimulant effects. It has been available for decades and is approved for short-term use.
GLP-1 medications mimic gut hormones, slowing gastric emptying and acting on appetite regulation. They are used as ongoing treatment for a chronic condition.
The subjective experience differs. Stimulant suppression tends to feel like being wired and not hungry; GLP-1 suppression tends to feel like being full and indifferent to food.
Duration is the real distinction
Phentermine’s approval is for short-term use, which limits its role for a condition that is chronic. Longer use happens in practice under prescriber supervision, and it is a decision with its own considerations.
GLP-1 medications are intended for continued use, with weight regain expected if they stop. That is a commitment, and it is also an honest reflection of obesity being treated as a chronic condition rather than a course of treatment.
Side effects compared
Phentermine: increased heart rate, raised blood pressure, insomnia, dry mouth, restlessness, irritability. Stimulant effects, in short.
GLP-1s: nausea, vomiting, diarrhea, constipation, reflux. Gastrointestinal, mostly, with a modest resting heart rate increase also recognised.
Neither list is trivial, and which is more tolerable is genuinely individual.
Cost and access
Phentermine is inexpensive and widely available as a generic, which is a real advantage for people without coverage.
GLP-1 medications are considerably more expensive, and coverage for weight management is frequently excluded. For many people this is the actual deciding factor rather than any clinical comparison.
Combination products
Phentermine appears in combination with topiramate in an approved weight management product, which has its own approval and its own considerations including pregnancy-related warnings. If that is being discussed, treat it as a separate medication rather than as phentermine with an addition.
Duration is the real distinction, since obesity is treated as a chronic condition, as weight regain after stopping sets out. Cost and coverage often decide between them, covered in employer coverage decisions.
Frequently asked questions
Which works better?
A clinical judgement based on your health and history rather than a general ranking.
Can I take both?
Combination approaches exist under specialist supervision. Not something to arrange yourself.
Is phentermine safer because it is older?
Age is not safety. It has its own contraindications, particularly cardiovascular.
Why is phentermine short-term only?
That is how it was approved. Longer use is a prescriber decision with its own considerations.
Will I regain weight after stopping either?
Regain after stopping is common with both, and well documented with GLP-1s.
Is phentermine easier to get covered?
Often cheaper and more widely available as a generic, which for some people is decisive.
Sources and further reading
- National Institute of Diabetes and Digestive and Kidney Diseases (NIH). Prescription medications to treat overweight and obesity. www.niddk.nih.gov
- MedlinePlus (US National Library of Medicine). Semaglutide injection: drug information. medlineplus.gov
- MedlinePlus (US National Library of Medicine). Tirzepatide injection: drug information. medlineplus.gov
GLP1Hub content is for general information and is not medical advice. Prices and coverage rules change often, so confirm current details with the provider, your insurer and your prescriber. See our editorial standards and medical disclaimer.
